SCHEMBL845190

SCHEMBL845190

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3C=CCN3C(=O)Cc3ccccn3)cc2)cc1)[C@@H]1C=CCN1C(=O)Cc1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.42
CYP3A4 P08684 1/20 0.42
ITGB1 P05556 1/20 0.40
ITGA4 P13612 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
CRACR2A Q9BSW2 2/20 0.38
HTR1A P08908 1/20 0.37
DRD2 P14416 1/20 0.37
FPR3 P25089 1/20 0.37
FPR2 P25090 1/20 0.37
PARP1 P09874 1/20 0.36
MAPK1 P28482 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845086 0.96 EPHX2 (0.40) EPHX2CYP3A4ITGB1ITGA4KMT2A
SCHEMBL10119279 0.91 EPHX2 (0.37) EPHX2CYP3A4ITGB1ITGA4KMT2A
SCHEMBL845441 0.91 GAA (0.43) EPHX2CYP3A4ITGB1ITGA4MAPK1
SCHEMBL845334 0.91 ITGB1 (0.39) EPHX2CYP3A4ITGB1ITGA4KMT2A
SCHEMBL10119337 0.84 ADRB1 (0.36) EPHX2CYP3A4ITGB1ITGA4HTR1A
SCHEMBL845099 0.82 ITGB1 (0.44) ITGB1ITGA4KMT2AHPGDCA1
SCHEMBL845622 0.81 ITGB1 (0.42) ITGB1ITGA4HTR1ADRD2PARP1
SCHEMBL845195 0.80 HCRTR1 (0.46) EPHX2CYP3A4MAPK1
SCHEMBL845214 0.79 ITGB1 (0.39) EPHX2ITGB1ITGA4KMT2AMEN1
SCHEMBL845098 0.79 ITGB1 (0.43) ITGB1ITGA4KMT2AHPGDCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed